These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26027633)

  • 1. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
    Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
    J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUT midline carcinoma of the parotid gland with mesenchymal differentiation.
    den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ
    Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
    Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
    J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
    Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
    BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
    Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
    Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
    Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
    Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.
    Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H
    Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
    Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
    Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature.
    Klijanienko J; Le Tourneau C; Rodriguez J; Caly M; Theocharis S
    Diagn Cytopathol; 2016 Sep; 44(9):753-6. PubMed ID: 27338676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
    Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
    Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
    Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
    J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midline carcinoma of children and young adults with NUT rearrangement.
    French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA
    J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue.
    Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H
    Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
    Fang W; French CA; Cameron MJ; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demystified molecular pathology of NUT midline carcinomas.
    French CA
    J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
    Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
    Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
    Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
    Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUT Carcinoma of the Sublingual Gland.
    Andreasen S; French CA; Josiassen M; Hahn CH; Kiss K
    Head Neck Pathol; 2016 Sep; 10(3):362-6. PubMed ID: 26586234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
    Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.